LONDON, Sept 17 (Reuters) - A medical journal criticised British drugmaker GlaxoSmithKline on Thursday for delaying access to key data from a trial of its antidepressant Seroxat that would have shown ...
A long criticised study on antidepressant use in adolescents has been flagged with an “expression of concern” by a leading ...
LONDON (AP) — Britain’s competition watchdog accused GlaxoSmithKline on Friday of paying off competitors to delay launches of their own versions of GSK’s best-selling antidepressant, Seroxat. The ...
July 2, 2012 — Psychiatrists who enjoyed free deep-sea fishing and golf at educational forums sponsored by drug maker GlaxoSmithKline more than a decade ago could have hardly known at the time that ...
CEO Emma Walmsley said GSK has had a minimal role in an effort by the FDA to update the prescribing information of the long-shelved drug leucovorin ...
A Chicago federal jury on Thursday awarded $3 million to the widow of a former leader of Reed Smith's corporate department, finding pharmaceutical giant GlaxoSmithKline plc liable for the 2010 suicide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback